Erschienen in:
17.10.2016 | Editorial
Statins in patients with sepsis and ARDS: is it over? We are not sure
verfasst von:
Danny McAuley, Pierre-Emmanuel Charles, Laurent Papazian
Erschienen in:
Intensive Care Medicine
|
Ausgabe 5/2017
Einloggen, um Zugang zu erhalten
Excerpt
Statins are lipid-lowering agents which act by inhibiting 3-hydroxy-3-methylglutaryl coenzyme A reductase and are generally used for cardiovascular prevention. Statins, however, also present anti-inflammatory and immunomodulating effects which could be of interest in sepsis and acute respiratory distress syndrome (ARDS). Many experimental investigations and some epidemiological studies support this theoretical beneficial effect. However, recent interventional studies which showed no benefit have been discouraging and do not support the use of statins in septic and/or ARDS patients. …